Examples of using Cellular therapy in English and their translations into Russian
{-}
-
Colloquial
-
Official
ISCT- International Society for Cellular Therapy.
Cellular therapy for kidney disease is based on science data.
Afanasyev, Editor-in Chief"Cellular Therapy and Transplantation", Director of R.
Cellular therapy works wonders not only in disease treatment but also in prevention.
The Journal focuses on both preclinical andclinical aspects of cellular therapy and transplantation.
Involvement in this international"Cellular Therapy and Transplantation" Journal will provide another method of exchange of novel results and ideas.
In the near future,we intend to expand our market by offering top-notch cellular therapy that delivers effective results at a low cost.
Therefore, in the last decade, patients with chronic degenerative diseases of the liver, primarily cirrhosis,get cellular therapy.
Swiss doctor Paul Niehans,who was one of the fathers of cellular therapy, developed in 1931-1949 years the so-called Fresh cell therapy. .
These super clean laboratories meet the most stringent requirements for the sterile production of the drugs used in cellular therapy.
Nemkov et al. has a 12-year experience in cellular therapy of coronary artery disease with local infusions of autologous bone marrow cell ABMC.
Keywords: intervertebral disc; degeneration of the intervertebral disc; bone morphogenetic protein;cell proliferation; cellular therapy.
The cellular therapy is referred to the most perspective ones as causing multicomponent and multidirectional impacts on many pathogenetic links of the disease.
These super clean laboratories meet the most stringent requirements for the sterile production of the drugs used in cellular therapy.
Cellular Therapy and Transplantation is published since 2009 as an international edition initiated by European specialists in hematology and transplantation.
Recent clinical trials have achieved favorable initial endpoints with improvements in cardiac function andclinical symptoms following cellular therapy.
Clinical experience has shown that after receiving cellular therapy, the survival of the transplanted kidney is much better, and the risk of further complications is decreased.
Moreover, we are glad to present both clinical and experimental articles that discuss various novel andactual aspects of transplantation and cellular therapy.
The doctors and cellular therapy experts at ProgenCell then proceed to personalize the therapies according to the patient's specific medical condition and needs.
We would be glad to get alternative views concern- ing gene editing, gene therapy and, especially,new approach- es to cellular therapy in oncology.
The German Society for organo-biotherapy eV is a non-profit organization,which was originally founded as a"Working Group for cellular therapy" on 26.06.1953 in Frankfurt/ Main and registered on 10.09.1953 under VR 2570 in the Register of Associations of Frankfurt/ M.
The CTT Journal is becoming popular among Russian- speaking specialists in the field of hematopoietic stem cell transplantation,due to broader coverage of different topics related to cellular therapy.
As it used to be, the Journal is aimed for publication of novel results andideas in the field of transplantation, cellular therapy, hematology and oncology obtained by Russian- and English-speaking clinicians and scientists, with young generation of hematologists being in scope, in order to spread these new data among the international community involved into the stem cell treatment of blood disorders and transplantation science.
We would be happy if our English- and Russian-speaking readers will be able to submit their original orreview articles to the Cellular Therapy and Transplantation Journal.
Hence, we wish much success in your studies, being in more close cooperation with Russian colleagues and the CTT Journal, which is ready to publish novel andoriginal results in clinical and experimental cellular therapy.
The achievement of both researchers inspired other scientists and doctors to develop hematopoietic stem cell transplantation and other methods of cellular therapy as a treatment for a variety of severe diseases.
The most advanced are those in the field of searching new immune checkpoints, development of highly efficient the immune adjuvants based on recombinant viruses to enhance the effect of anticancer vaccines,as well as design engineering of T cells' chimeric receptors to improve adoptive cellular therapy by giving it an antigen-specific constituent.
At present, a promising area of research is biological approaches for IVD degeneration, especially, the therapy with growth factors,gene therapy, cellular therapy and tissue engineering 5, 6.
Therefore, a synergistic effect between physical therapeutics and cellular therapies may exist.
Advancing Transfusion and Cellular Therapies Worldwide andNational Blood Foundation are pleased to announce the availability of funding in 2016 for scientific research projects related to transfusion medicine and cellular therapies.
